Advertisement

 

 

A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology.

A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology.
Author Information (click to view)

Tagliabue G, Faoro V, Rizzo S, Sblattero D, Saccani A, Riccio G, Bellini T, Salina M, Buscaglia M, Marcello A,


Tagliabue G, Faoro V, Rizzo S, Sblattero D, Saccani A, Riccio G, Bellini T, Salina M, Buscaglia M, Marcello A, (click to view)

Tagliabue G, Faoro V, Rizzo S, Sblattero D, Saccani A, Riccio G, Bellini T, Salina M, Buscaglia M, Marcello A,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Biochemical and biophysical research communications 2017 05 10492(4) 558-564 pii 10.1016/j.bbrc.2017.05.025

Abstract

Flaviviruses are widespread and cause clinically relevant arboviral diseases that impact locally and as imported travel-related infections. Direct detection of viraemia is limited, being typically undetectable at onset of symptoms. Therefore, diagnosis is primarily based on serology, which is complicated by high cross-reactivity across different species. The overlapping geographical distribution of the vectors in areas with a weak healthcare system, the increase of international travel and the similarity of symptoms highlight the need for rapid and reliable multi-parametric diagnostic tests in point-of-care formats. To this end we developed a bi-parametric serological microarray using recombinant NS1 proteins from Tick-borne encephalitis virus and West Nile virus coupled to a low-cost, label-free detection device based on the Reflective Phantom Interface (RPI) principle. Specific sequential detection of antibodies in solution demonstrates the feasibility of the approach for the surveillance and diagnosis of Flaviviruses.

Submit a Comment

Your email address will not be published. Required fields are marked *

twelve + five =

[ HIDE/SHOW ]